Long-term follow-up of children with in utero exposure to sulfonylurea medications.
Marissa S RodensteinMonica E BiancoMaegan U RamchalMichael MuriasRebecca L SiltonJami L JosefsonPublished in: Obesity science & practice (2021)
In summary, children with in utero sulfonylurea exposure had similar physical measurements compared to children with insulin exposure and lower performance on a measure of executive function (inhibition), which is associated with adverse health outcomes.